The Resistance and Immune Response to Palbociclib in Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IV
Interventions: GENETIC: tissue biopsy, blood sample
Sponsor: Samsung Medical Center